Navigation Links
Interferon Reduces, Eliminates Viral Infections in Heart Failure Patients
Date:11/11/2008

ted as responders. This resulted in clearance rates of 40 percent and 50 percent in the chronic adenovirus-enterovirus group, depending on the dose, and clearance or reduction rates of 31.8 percent to 35.7 percent in the parvovirus group, Schultheiss said.

Secondary endpoints included change in NYHA functional class; performance on a six-minute walk test; individual clinical symptoms; quality of life and echocardiographic left ventricular ejection fraction (LVEF) -- a measure of the heart's ability to pump blood -- both at rest and on exertion; and several other measures of heart function and inflammation. No significant changes in these were reported at 24 weeks after treatment, although there were trends toward improvement.

Co-authors are: Cornelia Piper, M.D., Ph.D.; Olaf Sowade, M.D.; Kristjan Karason, M.D., Ph.D.; Joachim-Friedrich Kapp, M.D., Ph.D.; Karl Wegscheider, Ph.D., M.Sc.; Georg Groetzbach, M.D.; Finn Waagstein, M.D., Ph.D.; Eloisa Arbustini, M.D.; Harald Siedentop, Ph.D.; and Uwe Kuehl, M.D., Ph.D. Individual author disclosures can be found on the abstract.

The study was funded by Bayer Health Care.

Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at http://www.americanheart.org/corporatefunding.


'/>"/>
SOURCE American Heart Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Study shows that high-dose, high-frequency interferon produces no additional benefit
2. GenOdyssee Receives Notice of Allowance from U.S. Patent Office for Improved Interferon-Alpha Aimed at Hepatitis C
3. PEGINTRON(TM) and REBETOL(R) Approved in European Union for Retreating Hepatitis C Patients Who Failed Previous Pegylated or Non-Pegylated Interferon Therapy
4. Interferon does not slow or stop hepatitis C from worsening, study finds
5. For the First Time this Winter Consumers Have an Electronic Green Solution that Eliminates 99.97 Percent of Indoor Air Pollution
6. Ultra-High Pressure Processing Eliminates Salmonella in Fresh Tomatoes
7. Radian Guaranty Inc. Eliminates Stated Income and Stated Asset Programs
8. Verathon Inc. Introduces GlideScope(R) Ranger Single Use Video Laryngoscope for Emergency Departments, EMS and Military; Enables Fast Intubations and Eliminates Time-Consuming Disinfection
9. Roche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real-Time PCR Platform
10. Doctor Recommends New Powerful Natural Antiviral Against the Flu
11. Researchers estimate lives lost due to delay in antiretroviral drug use for HIV/AIDS in South Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2015)... May 23, 2015 Injury lawyer Steven H. ... been passed by the Maryland legislature but which has not ... General Assembly passed HB 449 with overwhelming bipartisan ... not signed it into law. This bill ensures that fracking ... growing that demonstrates the danger of fracking to our water ...
(Date:5/22/2015)... River Valley Health Partners (RVHP) Board ... system’s Chief Financial Officer (CFO), will be leaving the ... the company CFO since 2011. , The Board of ... health system as CFO. Wesley will oversee the health ... Board of Trustees conducts a formal search for a ...
(Date:5/22/2015)... Commack, Long Island, NY (PRWEB) May 22, 2015 ... Spa announces that June 17, 2015, the Annual ... will take place. Since 2007, Hands On HCMT offers drastically ... the massage therapists and estheticians have enough sessions, through what ... summer. And, it is wonderful for the community as well. ...
(Date:5/22/2015)... LINCOLN, R.I. (PRWEB) May 22, 2015 Memorial ... so Amica Insurance is offering some tips to ... National Safety Council, there will be 383 traffic fatalities this ... tips from the National Highway Traffic Safety Association: , ... everyone in the vehicle is wearing a seatbelt, whether they’re ...
(Date:5/22/2015)... 22, 2015 According to Berks and ... drug related death, totaling almost 2,500 confirmed drug deaths, as ... state officials, totals 2,489 deaths stemming from legal and illegal ... loses seven people every day to fatal overdoses or other ... out as one of the most rife with drug related ...
Breaking Medicine News(10 mins):Health News:Baltimore Attorney Urges Governor Hogan to Sign the Fracking Moratorium Bill 2Health News:Baltimore Attorney Urges Governor Hogan to Sign the Fracking Moratorium Bill 3Health News:River Valley Health Partners Announces CFO Transition, Appointment of Interim CFO 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 3Health News:Amica Has 4 Road Safety Tips for Memorial Day Weekend 2Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2
... 2008 From June 25 to 28, physicians, researchers, ... the combined study of neurosciences and music, will gather ... conference: The Neurosciences and music III Disorders and ... has organized on the wave of the extraordinary success ...
... New research by scientists at the University of North ... an important family of proteins known to function at the ... , The findings have potential implications for drug development as ... target of forty to fifty percent of modern medicinal drugs, ...
... WORTH, Texas, Feb. 12 Benjamin M. ... Group, Inc. (USHEALTH), a leading,national health insurer ... the self-employed, announced today the promotion of ... Administration Officer. In this,expanded role, Kober will ...
... has published a,feature story on the terrible incidence of ... dog owners, and treatments and scientific,research under way to ... release.,Morris Animal Foundation (MAF) is cited as leading a ... to 20 years. MAF can help provide the,press with ...
... Approximately 7 Million Shares Shorted Since March 2006 According to ... ... BioElectronics,Corporation (Pink Sheets: BIEL) announced today that BUYINS.NET, http://www.buyins.net, ... short sale data to February 2008. From March 2006 to,February ...
... Rutherford-Appleton Laboratories have developed one of the Worlds largest ... scanners. The new technology will allow doctors to produce ... at a lower-cost to the healthcare profession. , The ... the 4.5m Basic Technology MI-3 Consortium, will help in ...
Cached Medicine News:Health News:Neuromusic showtime 2Health News:Neuromusic showtime 3Health News:Discovery of 'overdrive' protein could broaden drug design options 2Health News:USHEALTH Group Announces Appointment of Executive Vice President 2Health News:BioElectronics Corporation (BIEL) SqueezeTrigger Price is $0.11 2Health News:BioElectronics Corporation (BIEL) SqueezeTrigger Price is $0.11 3Health News:BioElectronics Corporation (BIEL) SqueezeTrigger Price is $0.11 4Health News:BioElectronics Corporation (BIEL) SqueezeTrigger Price is $0.11 5Health News:BioElectronics Corporation (BIEL) SqueezeTrigger Price is $0.11 6
(Date:5/22/2015)... 22, 2015 /CNW/ - More than fifty years ago, Thalidomide ... sickness in expectant mothers. Tragically, Thalidomide caused serious and permanent ... Support has been provided to survivors over the ... Canada in 1991 and settlements from drug ... legal obligation to provide support, we have a clear moral ...
(Date:5/22/2015)... -- The Assistance Fund announces the addition of its ... for copay to individuals diagnosed with Melanoma. ... the Melanoma Copay Assistance Program to our portfolio of ... "With each additional program we are closer to achieving ... one is denied access to medications due to an ...
(Date:5/22/2015)... Texas , May 22, 2015 ... million in 2014 and is estimated to reach $90.7 million ... 2019. Browse through the TOC of North America ... segments, with the help of various tables and figures. ... receive 10% customization on this report.   ...
Breaking Medicine Technology:Statement from Minister Ambrose on Thalidomide 2Statement from Minister Ambrose on Thalidomide 3The Assistance Fund Adds Melanoma Assistance Program 2North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 2North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 3
... Schein, Inc., (NASDAQ: HSIC ), the largest provider ... announced today that Steven Paladino, Executive Vice President and ... Stanley Global Healthcare Conference.  The conference is taking place at ... Schein,s presentation is scheduled to begin at 3:20 p.m. EDT ...
... Pharmaceuticals, Inc. (Nasdaq: AMLN ), Eli ... and Alkermes, Inc. (Nasdaq: ALKS ) ... -4 trials demonstrating patients treated with the investigational ... significant improvements in select cardiovascular risk factors, in ...
Cached Medicine Technology:Henry Schein to Present at the Morgan Stanley Global Healthcare Conference 2Analyses Find Type 2 Diabetes Patients Treated with BYDUREON™ Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD 2011 2Analyses Find Type 2 Diabetes Patients Treated with BYDUREON™ Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD 2011 3Analyses Find Type 2 Diabetes Patients Treated with BYDUREON™ Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD 2011 4Analyses Find Type 2 Diabetes Patients Treated with BYDUREON™ Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD 2011 5Analyses Find Type 2 Diabetes Patients Treated with BYDUREON™ Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD 2011 6Analyses Find Type 2 Diabetes Patients Treated with BYDUREON™ Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD 2011 7Analyses Find Type 2 Diabetes Patients Treated with BYDUREON™ Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD 2011 8Analyses Find Type 2 Diabetes Patients Treated with BYDUREON™ Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD 2011 9
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: